Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Cyrus T et al. Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. 2006 Atherosclerosis pmid:16326168
Zheng YN et al. Effects of compounds in leaves of Salix matsudana on arachidonic acid metabolism. 2005 Yakugaku Zasshi pmid:16327246
Yugar-Toledo JC et al. Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine. 2005 J Clin Hypertens (Greenwich) pmid:16330894
Sánchez M et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. 2006 J. Hypertens. pmid:16331104
Gerasimovska-Kitanovska B et al. Decreased nitric oxide in women with essential hypertension in prehypertensive phase. 2005 Croat. Med. J. pmid:16342341
Mauri P et al. LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. 2006 J Pharm Biomed Anal pmid:16343838
Lin JS et al. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. 1992 J. Urol. pmid:1635125
Mabe K et al. Effects of norethisterone on pressor response to angiotensin II in men. 1992 Obstet Gynecol pmid:1635747
Xu S et al. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. 2006 Diabetes pmid:16380483
Michel F et al. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16385086
Arakawa M et al. Effects of ulinastatin, an antiprotease, on alloxan-induced lung injury in dogs. 1992 May-Jun Clin Ther pmid:1638581
de la Cruz JP et al. Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase. 1992 Gen. Pharmacol. pmid:1639242
Treiber G et al. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. 2006 Aliment. Pharmacol. Ther. pmid:16393293
Yao X et al. [The changes of some vasoactive substances after operation in patients with obstructive sleep apnea-hypopnea syndrome]. 2005 Lin Chuang Er Bi Yan Hou Ke Za Zhi pmid:16398051
Meydani SN et al. Lung eicosanoid synthesis is affected by age, dietary fat and vitamin E. 1992 J. Nutr. pmid:1640256
Yang YY et al. Roles of anandamide in the hepatic microcirculation in cirrhotic rats. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:16407591
Kong XY and Gong PL [Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation]. 2005 Yao Xue Xue Bao pmid:16408809
Santilli F et al. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. 2006 J. Am. Coll. Cardiol. pmid:16412866
Myers SI and Hernandez R Role of oxygen-derived free radicals on rat splanchnic eicosanoid production during acute hemorrhage. 1992 Prostaglandins pmid:1641500
Lee KS et al. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. 2006 Pharmacol. Res. pmid:16420980
Baltzer WI et al. Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. 2006 Am. J. Vet. Res. pmid:16426215
Okuda Y et al. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy. 1992 Arzneimittelforschung pmid:1642679
Osterud B et al. Increased lipopolysaccharide-induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2. 1992 Blood Coagul. Fibrinolysis pmid:1643209
Ciabattoni G et al. Determinants of platelet activation in Alzheimer's disease. 2007 Neurobiol. Aging pmid:16442186
Wang LH et al. Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation. 2006 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:16445701
Evangelista V et al. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. 1991 Blood pmid:1645603
Fujimori T et al. A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets. 1991 Jpn. J. Pharmacol. pmid:1645815
Chiu HF et al. Mechanisms involved in the antiplatelet effect of C-phycocyanin. 2006 Br. J. Nutr. pmid:16469164
Rabinovici R et al. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. 1991 Circ. Res. pmid:1647275
Gundel RH et al. Antigen-induced mediator release in primates. 1991 Am. Rev. Respir. Dis. pmid:1648317
Drummer C et al. Comparison of anti-platelet properties of molsidomine, isosorbide-5-mononitrate and placebo in healthy volunteers. 1991 Eur. Heart J. pmid:1648488
Bogani P et al. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. 2007 Atherosclerosis pmid:16488419
Rossoni G et al. Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats. 2006 Pharmacol. Res. pmid:16488624
Sun FF et al. Biochemical and functional differences between eosinophils from animal species and man. 1991 J. Leukoc. Biol. pmid:1649240
Lepäntalo A et al. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. 2006 Thromb. Haemost. pmid:16493486
Wynn RL and Cook J Does ibuprofen block the cardioprotective effects of aspirin in dental patients? 2006 Jan-Feb Gen Dent pmid:16494111
Laporte J et al. Metabolism of arachidonic acid by guinea pig Clara cells. 1991 Prostaglandins pmid:1649482
RÃ¥ngemark C and Wennmalm A Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. 1991 Clin. Sci. pmid:1649717
Knight KR et al. Enhancement of ischaemic rabbit skin flap survival with the antioxidant and free-radical scavenger N-acetylcysteine. 1991 Clin. Sci. pmid:1649722
White JO et al. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring. 1991 Contraception pmid:1649733
Wilder-Smith CH et al. Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects. 2006 Scand. J. Gastroenterol. pmid:16497612
Túri S et al. The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation. 1991 Pediatr. Nephrol. pmid:1651098
Chen F et al. Treatment of S antigen uveoretinitis with lipoxygenase and cyclo-oxygenase inhibitors. 1991 Ophthalmic Res. pmid:1651467
Kurosawa S et al. Effects of ulinastatin on pulmonary artery pressure during abdominal aortic aneurysmectomy. 2006 J Clin Anesth pmid:16517327
Myers SI et al. Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. 2006 J. Vasc. Surg. pmid:16520177
Pratt HL et al. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome. 1991 Am. J. Vet. Res. pmid:1652907
Renesto P et al. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine. 1991 Br. J. Pharmacol. pmid:1653073
Rossoni G et al. Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs. 2007 Pulm Pharmacol Ther pmid:16533614
Fu JH et al. [Protective effects of saponines of stem and leaf of Panax notoginseng on acute myocardial ischemia in anaesthetic dogs]. 2006 Zhongguo Zhong Yao Za Zhi pmid:16548173
Kanazawa S et al. Aspirin reduces adverse effects of gefitinib. 2006 Anticancer Drugs pmid:16550000
Stahl RA et al. The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury. 1991 J. Am. Soc. Nephrol. pmid:1655092
Li L [Effects of svate on platelet morphology and function in patients with coronary heart disease and hypertension]. 1991 Zhonghua Xin Xue Guan Bing Za Zhi pmid:1655375
Cambria RA et al. The influence of arachidonic acid metabolites on leukocyte activation and skeletal muscle injury after ischemia and reperfusion. 1991 J. Vasc. Surg. pmid:1656104
Weigel G et al. Regulation of eicosanoid release in human umbilical endothelial cells. 1991 Thromb. Res. pmid:1656543
Chanez P et al. Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. 1991 Am. Rev. Respir. Dis. pmid:1656824
Park HS et al. Dietary trans-10, cis-12 and cis-9,trans-11 conjugated linoleic acids induce apoptosis in the colonic mucosa of rats treated with 1,2-dimethylhydrazine. 2006 J Med Food pmid:16579724
Pararajasegaram G et al. Suppression of S antigen-induced uveitis by vitamin E supplementation. 1991 Ophthalmic Res. pmid:1658702
Griffin MP et al. Ibuprofen therapy in experimental porcine gram-negative septic shock. 1991 Resuscitation pmid:1658896
Perneby C et al. Dose- and time-dependent antiplatelet effects of aspirin. 2006 Thromb. Haemost. pmid:16601836
Niemi TT et al. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. 2006 Blood Coagul. Fibrinolysis pmid:16607076
Shen J [Effects of verapamil on prostacyclin, thromboxane and pancreatic blood flow of rats with experimental acute pancreatitis]. 1991 Zhonghua Yi Xue Za Zhi pmid:1660773
Gudewicz PW and Frewin MB Surface contact modulation of inflammatory macrophage antibody dependent cytotoxicity and prostanoid release. 1991 J. Cell. Physiol. pmid:1660899
Murphy CT et al. Comparison of the role of protein kinase C in platelet functional responses induced by three different mechanisms, PAF, ionomycin and arachidonic acid. 1991 Biochim. Biophys. Acta pmid:1661165
Fujimoto Y et al. Monochloramine potently inhibits arachidonic acid metabolism in rat platelets. 2006 Biochem. Biophys. Res. Commun. pmid:16615995
Laleman W et al. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. 2006 Eur. J. Clin. Invest. pmid:16620286
Cheung PY et al. Platelet dysfunction in asphyxiated newborn piglets resuscitated with 21% and 100% oxygen. 2006 Pediatr. Res. pmid:16627873
Fontana P et al. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. 2006 J. Thromb. Haemost. pmid:16634751
Markuszewski L et al. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? 2006 Basic Clin. Pharmacol. Toxicol. pmid:16635110
Alanko J et al. Catecholamines decrease leukotriene B4 and increase thromboxane B2 synthesis in A23187-stimulated human whole blood. 1991 Prostaglandins pmid:1664115
Zhou Y et al. Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. 2006 Circ. Res. pmid:16645140
Yin M et al. [Experimental study of effects of cyclooxygenase-2 inhibitor on apoptosis of hypoxic myocardial cells in vitro]. 2006 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:16647015
Ahmad S et al. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. 2006 Eur. J. Pharmacol. pmid:16650843
Maddox JF et al. Dietary selenium effects on milk eicosanoid concentration in dairy cows during coliform mastitis. 1991 Prostaglandins pmid:1665569
Huang TF et al. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom. 1991 Thromb. Haemost. pmid:1665595
Hatmi M et al. Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics. 1991 Br. J. Pharmacol. pmid:1665743
Hsu P et al. Effects of ischemia/reperfusion on brain tissue prostanoids and leukotrienes in newborn pigs. 1991 Prostaglandins pmid:1666191
Xu XY and Wang Q [The influence of sodium ferulate on hypotensive effect and urinary excretion of TXB2 after captopril in essential hypertensive patients]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1667512
Minuz P et al. Prostaglandin I2 and thromboxane B2 biosynthesis and haemodynamic effects of lisinopril. 1991 J Hypertens Suppl pmid:1668010
Vranic II et al. Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16682179
Huntjens DR et al. Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers. 2006 Br. J. Pharmacol. pmid:16682968
Shemesh E et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. 2006 May-Jun Psychosomatics pmid:16684940
Munsterhjelm E et al. Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers. 2006 Br J Anaesth pmid:16698862
Kranzhofer R and Ruef J Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism. 2006 Platelets pmid:16702043
Ohmori T et al. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. 2006 J. Thromb. Haemost. pmid:16706971
Van Geet C et al. Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome. 1991 Lancet pmid:1670726
Goldman G et al. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. 1991 Circ. Res. pmid:1672629
Tulppala M et al. Thromboxane dominance and prostacyclin deficiency in habitual abortion. 1991 Lancet pmid:1672969
Lee KS et al. Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action. 2006 Arch. Pharm. Res. pmid:16756082
Sziegoleit W et al. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects. 1991 Pharmazie pmid:1677468
Kwon JS et al. Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. 1991 Am. J. Clin. Nutr. pmid:1677525
Lianos EA et al. Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids. 1991 J. Clin. Invest. pmid:1677947
Peck OM et al. The phosphatidylinositol 3 kinase pathway regulates tolerance to lipopolysaccharide and priming responses to Staphylococcus aureus and lipopolysaccharide. 2006 Shock pmid:16783195
Kanda N and Watanabe S Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. 2006 Biochem. Pharmacol. pmid:16784723
Frelinger AL et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. 2006 Circulation pmid:16785341
Cox D et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. 2006 Stroke pmid:16794200
Jeng JH et al. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. 2007 Atherosclerosis pmid:16797553
Jones WO and Emery DL Demonstration of a range of inflammatory mediators released in trichostrongylosis of sheep. 1991 Int. J. Parasitol. pmid:1680110
Zhao Y et al. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis. 2006 Ann. Allergy Asthma Immunol. pmid:16802773
Brenneis C et al. Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. 2006 FASEB J. pmid:16816110
Murphy KJ et al. Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. 2006 Asia Pac J Clin Nutr pmid:16837436